Published by Josh White on 3rd August 2021
(Sharecast News) - Pharmaceutical biotechnology company Allergy Therapeutics announced positive primary results from an ex-vivo biomarker study on Tuesday, evaluating its novel virus-like particle (VLP)-based peanut allergy vaccine candidate, VLP Peanut.
URL: http://www.digitallook.com/dl/news/story/32031304/...